Smoking cessation program for patients with diabetes-success factors
A. Korkontzelou (Athens, Greece), S. Driva (Athens, Greece), S. Schoretsaniti (Athens, Greece), Z. Barbaressou (Athens, Greece), V. Vasileiou (Athens, Greece), V. Saltagianni (Athens, Greece), A. Osarogue (Athens, Greece), S. Gyftopoulos (Athens, Greece), M. Andritsou (Athens, Greece), S. Pappa (London, United Kingdom), S. Tonstad (Oslo, Norway), C. Gratziou (Athens, Greece), N. Tentolouris (Athens, Greece), P. Katsaounou (Athens, Greece)
Source: International Congress 2022 – Epidemiology: products and diseases
Session: Epidemiology: products and diseases
Session type: Thematic Poster
Number: 3926
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Korkontzelou (Athens, Greece), S. Driva (Athens, Greece), S. Schoretsaniti (Athens, Greece), Z. Barbaressou (Athens, Greece), V. Vasileiou (Athens, Greece), V. Saltagianni (Athens, Greece), A. Osarogue (Athens, Greece), S. Gyftopoulos (Athens, Greece), M. Andritsou (Athens, Greece), S. Pappa (London, United Kingdom), S. Tonstad (Oslo, Norway), C. Gratziou (Athens, Greece), N. Tentolouris (Athens, Greece), P. Katsaounou (Athens, Greece). Smoking cessation program for patients with diabetes-success factors. 3926
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|